Brief: Anthera Pharmaceuticals Q3 loss per share $0.29

Anthera Pharmaceuticals

06/11/2015 22:18

Nov 6 (Reuters) - Anthera Pharmaceuticals Inc  ANTH.O : 
 * Provides business update and reports third quarter 2015 financial results 
 * Q3 loss per share $0.29 
 * Says to regain all Japan rights to blisibimod following termination of Asia 
   partnership 
 * Says completed capsule manufacturing in support of the solution clinical 
   study 
 
* Source text for Eikon  ID:ANTH.O  
 
* Further company coverage  ANTH.O  ((Bengaluru Newsroom; +1 646 223 8780))